Previous close | 0.7978 |
Open | 0.8200 |
Bid | 0.8115 x 900 |
Ask | 0.8184 x 800 |
Day's range | 0.7614 - 0.8450 |
52-week range | 0.7000 - 23.3800 |
Volume | |
Avg. volume | 448,273 |
Market cap | 47.685M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.8250 |
Earnings date | 15 Apr 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.50 |
The big shareholder groups in Brooklyn ImmunoTherapeutics, Inc. ( NASDAQ:BTX ) have power over the company...
Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company’s Future During May 25, 2021 Shareholder Update Call
Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing